| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.03 | 0.8 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |